Premier Biomedical, Inc.
BIEI
$0.0005
-$0.0001-16.67%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | 14.30K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.30K | -- | -- | -- | -- |
| Cost of Revenue | 13.00K | -- | -- | -- | -- |
| Gross Profit | 1.40K | -- | -- | -- | -- |
| SG&A Expenses | 328.30K | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 341.00K | -- | -- | -- | -- |
| Operating Income | -326.70K | -- | -- | -- | -- |
| Income Before Tax | -374.40K | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.37 | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -374.40K | -- | -- | -- | -- |
| EBIT | -326.70K | -- | -- | -- | -- |
| EBITDA | -323.90K | -- | -- | -- | -- |
| EPS Basic | -0.02 | -- | -- | -- | -- |
| Normalized Basic EPS | -0.01 | -- | -- | -- | -- |
| EPS Diluted | -0.02 | -- | -- | -- | -- |
| Normalized Diluted EPS | -0.01 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 209.40M | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 209.40M | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
